VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 64 filers reported holding VIRACTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $18,796 | -65.8% | 12,874 | -0.1% | 0.00% | -50.0% |
| Q3 2022 | $55,000 | -1.8% | 12,884 | -10.8% | 0.00% | -20.0% |
| Q2 2022 | $56,000 | -39.8% | 14,450 | -26.3% | 0.01% | -37.5% |
| Q1 2022 | $93,000 | -21.8% | 19,605 | -40.0% | 0.01% | -27.3% |
| Q4 2021 | $119,000 | – | 32,651 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 288,571 | $1,232,000 | 0.82% |
| Samsara BioCapital, LLC | 689,709 | $2,945,000 | 0.69% |
| BVF INC/IL | 3,614,662 | $15,435,000 | 0.64% |
| Rubric Capital Management LP | 994,801 | $4,248,000 | 0.21% |
| HAMILTON LANE ADVISORS LLC | 35,791 | $153,000 | 0.06% |
| MAI Capital Management | 637,641 | $2,723,000 | 0.05% |
| Jasper Ridge Partners, L.P. | 92,939 | $397,000 | 0.03% |
| BOURGEON CAPITAL MANAGEMENT LLC | 20,500 | $88,000 | 0.02% |
| Ergoteles LLC | 132,636 | $566,000 | 0.02% |
| Laurion Capital Management LP | 698,000 | $2,980,000 | 0.02% |